Picard Medical, Inc. (PMI) (CIK 0002030617) filed Form 8-K

Picard Medical, Inc. (ticker: PMI, CIK 0002030617) filed a Form 8-K with the U.S. Securities and Exchange Commission on August 20, 2026, covering the period ending August 19, 2026, per the SEC EDGAR filing.

The filing covers items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits), according to the SEC EDGAR record. Item 7.01 filings are typically used by public companies to satisfy fair disclosure obligations under SEC Regulation FD, ensuring that material information provided to select parties is simultaneously made available to the general public. Item 9.01 indicates that supporting financial statements or exhibits were attached to the disclosure.

The specific nature of the Regulation FD disclosure — including what information was shared, with whom, and in what context — is not detailed in the available EDGAR metadata. The full text of the filing and any attached exhibits would contain those particulars but were not provided in the source data.

Picard Medical, Inc. is a publicly traded company listed under the PMI ticker. Beyond its SEC registration details, no additional background on the company's business, founding date, prior fundraising history, or operational profile is available from the current source material.

Regulation FD filings via Form 8-K Item 7.01 are a routine compliance mechanism for public companies, but the substance of any accompanying disclosure can range from earnings guidance and business updates to partnership announcements or executive communications. Without the full exhibit package, the materiality and market relevance of PMI's specific disclosure cannot be assessed from the SEC EDGAR filing metadata alone.

The complete filing, identified by accession number 0001437749-26-028585, is available through SEC EDGAR for review of the full disclosure and any attached exhibits.